SANGAMO THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5024 USD | -6.95% |
|
-7.61% | -7.53% |
| Mar. 22 | Sangamo Therapeutics Prices $24 Million Registered Direct Offering | MT |
| Mar. 14 | Sangamo Therapeutics Pushes Neurology Programs Toward Clinical Development, Wedbush Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Bio Therapeutic Drugs | -6.95% | -7.61% | -7.53% | -60.44% | -95.56% | 112M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- SGMO Stock
- Charts Sangamo Therapeutics, Inc.
- Comparison Chart